Published in N Engl J Med on February 11, 1999
Putting tumours in context. Nat Rev Cancer (2001) 12.37
The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell (1999) 6.08
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med (2010) 3.44
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech (2011) 2.97
Three-dimensional context regulation of metastasis. Clin Exp Metastasis (2008) 2.49
Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J (2007) 1.84
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene (2000) 1.77
Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia (2009) 1.55
Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle (2011) 1.46
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol (2003) 1.46
A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control (2010) 1.35
Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat (2008) 1.15
Criteria for the evaluation of large cohort studies: an application to the nurses' health study. J Natl Cancer Inst (2008) 1.06
The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. J Cancer Res Clin Oncol (2011) 1.03
Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol (2000) 1.01
The diagnosis and management of pre-invasive breast disease: pathological diagnosis--problems with existing classifications. Breast Cancer Res (2003) 0.98
A transient parabiosis skin transplantation model in mice. Nat Protoc (2012) 0.94
Pathology and clinical relevance of radial scars: a review. J Clin Pathol (2003) 0.93
Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat (2007) 0.89
First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat (2016) 0.85
Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells. PLoS One (2012) 0.85
Transaxillary endoscopic excision of benign breast lumps: a new technique. Surg Endosc (2008) 0.85
Radial scars diagnosed at stereotactic core-needle biopsy: surgical biopsy findings. Eur Radiol (2006) 0.83
Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat (2013) 0.82
Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice. Nat Protoc (2012) 0.81
An isolated tumor perfusion model in mice. Nat Protoc (2012) 0.81
Tenascin C in metastasis: A view from the invasive front. Cell Adh Migr (2015) 0.81
Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program. World J Surg Oncol (2010) 0.80
The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era: historical perspectives. Breast Cancer Res (1999) 0.79
Radial scars and breast cancer. N Engl J Med (1999) 0.79
Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary? Am J Surg Pathol (2015) 0.78
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile. Histopathology (2016) 0.78
Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion. Oncotarget (2017) 0.78
A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme. Ann R Coll Surg Engl (2010) 0.77
Radial scar/complex sclerosing lesions: a clinicopathologic correlation study from a single institution. Ann Diagn Pathol (2014) 0.75
Imaging features of complex sclerosing lesions of the breast. Ultrasonography (2013) 0.75
Radial scars and subsequent breast cancer risk: a meta-analysis. PLoS One (2014) 0.75
Clinical Images: Radial Scar of the Breast. Ochsner J (2015) 0.75
Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol (2016) 0.75
Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index. Oncotarget (2017) 0.75
Awareness and current knowledge of breast cancer. Biol Res (2017) 0.75
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med (1994) 5.72
The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60
Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization. Arch Gen Psychiatry (1987) 4.30
Junction adhesion molecule is a receptor for reovirus. Cell (2001) 4.00
Patterned acquisition of skin barrier function during development. Development (1998) 3.88
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst (1996) 3.45
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev (1995) 2.99
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol (1995) 2.96
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
Impact of a school-based interdisciplinary intervention on diet and physical activity among urban primary school children: eat well and keep moving. Arch Pediatr Adolesc Med (1999) 2.60
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res (1999) 2.55
Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol (1998) 2.53
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst (1992) 2.50
Coffee, caffeine, and cardiovascular disease in men. N Engl J Med (1990) 2.49
Association between psychosocial work characteristics and health functioning in American women: prospective study. BMJ (2000) 2.23
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Ontario Child Health Study: reliability and validity of the general functioning subscale of the McMaster Family Assessment Device. Fam Process (1988) 2.15
Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem (2000) 2.12
Outcome, prognosis, and risk in a longitudinal follow-up study. J Am Acad Child Adolesc Psychiatry (1992) 2.08
The epidermis: rising to the surface. Curr Opin Genet Dev (1994) 2.08
Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ (1989) 2.07
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol (1992) 2.05
Evaluation of suicide awareness programmes delivered to veterinary undergraduates and academic staff. Vet Rec (2010) 2.03
Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol (2001) 2.01
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00
p53 antigen loss in stored paraffin slides. N Engl J Med (1995) 1.99
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89
Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences. QJM (1997) 1.84
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol (1999) 1.77
Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev (1997) 1.75
Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin (1997) 1.75
Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst (1994) 1.75
Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med (2000) 1.73
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73
PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor. J Cell Biol (1986) 1.71
The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol (1990) 1.71
Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci U S A (1991) 1.70
Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol (1999) 1.65
Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebo-controlled trial. Endoscopy (2012) 1.61
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol (1991) 1.59
Papillary lesions of the breast: selected diagnostic and management issues. Histopathology (2008) 1.53
Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer (1996) 1.53
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol (2001) 1.51
(131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome. Eur J Surg Oncol (2001) 1.51
Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer (1997) 1.50
Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci U S A (2001) 1.49
Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer (1996) 1.49
Rapid, sequential changes in surface morphology of PC12 pheochromocytoma cells in response to nerve growth factor. J Cell Biol (1979) 1.48
Comparison of rapid changes in surface morphology and coated pit formation of PC12 cells in response to nerve growth factor, epidermal growth factor, and dibutyryl cyclic AMP. J Cell Biol (1984) 1.48
The pathogenicity of Mycobacterium tuberculosis during chemotherapy. Eur Respir J (1990) 1.48
Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys (1999) 1.46
Faecal carriage of verocytotoxin-producing Escherichia coli O157 in cattle and sheep at slaughter in Great Britain. Vet Rec (2002) 1.46
Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg (1998) 1.44
Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma. Leuk Lymphoma (2014) 1.41
National survey for Salmonella in pigs, cattle and sheep at slaughter in Great Britain (1999-2000). J Appl Microbiol (2004) 1.41
Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer (1997) 1.40
Septic shock syndrome in the surgical wound care patient. J Foot Surg (1992) 1.39
Adolescence to adulthood--a journey or a struggle? Qld Nurse (2000) 1.38
Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology (1989) 1.35
Raised proinsulin concentration as early indicator of beta cell dysfunction. BMJ (1991) 1.34
Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control (1994) 1.34
Using theory to understand the multiple determinants of low participation in worksite health promotion programs. Health Educ Behav (2001) 1.34
Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med (1988) 1.33
Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol (2000) 1.31
Role of cardiorespiratory abnormalities, smoking and dive characteristics in the manifestations of neurological decompression illness. Clin Sci (Lond) (1994) 1.30
Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry (2008) 1.28
Postmenopausal hormone use, screening, and breast cancer: characterization and control of a bias. Epidemiology (2001) 1.28
Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol (1990) 1.26
Predictors of weight change in men: results from the Health Professionals Follow-up Study. Int J Obes Relat Metab Disord (1998) 1.25
Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol (1993) 1.24
Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.24